Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage re...
Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Background: Patients with end-stage renal disease (ESRD) undergoing long-term haemodialysis exhibit low L-carnitine and elevated acylcarnitine concentrations. This study evaluated endogenous concentrations of an array of acylcarnitines (carbon chain length up to 18) in healthy individuals and ESRD patients receiving haemodialysis, and examined the...
Alternative Titles
Full title
Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_68589964
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68589964
Other Identifiers
ISSN
0004-5632
E-ISSN
1758-1001
DOI
10.1258/0004563054889954
